Disc Medicine (IRON) Non-Current Debt (2020 - 2026)

Disc Medicine (IRON) has reported Non-Current Debt for 5 consecutive years, with $59.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Non-Current Debt rose 106.49% year-over-year to $59.3 million; the TTM figure through Jun 2026 stood at $59.3 million (up 106.49% YoY), while the FY2025 annual figure was $29.2 million, up 2.96% from the prior year.
• Non-Current Debt grew to $59.3 million in Q2 2026 per IRON's latest filing, from $29.4 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $59.3 million in Q2 2026 and bottomed at $28.3 million in Q4 2024.
• Historically, Non-Current Debt has averaged $33.2 million across 3 years, with a median of $28.9 million in 2025.
• On a YoY basis, Non-Current Debt climbed as much as 106.49% in 2026 and fell as far as 2.93% in 2026.
• Disc Medicine's Non-Current Debt stood at $28.3 million in 2024, then rose by 2.96% to $29.2 million in 2025, then soared by 103.5% to $59.3 million in 2026.
• Business Quant data shows IRON's Non-Current Debt at $59.3 million in Q2 2026, $29.4 million in Q1 2026, and $29.2 million in Q4 2025.